In vitro model of neurotoxicity of Aβ 1-42 and neuroprotection by a pentapeptide: Irreversible events during the first hour

Neurobiology of Disease

Volumn 17, Issue 3, 2004, Pages 507-515

  Datki, Zsolt ^a   Papp, Rita ^a   Zádori, Dénes ^a   Soós, Katalin ^a   Fülöp, Lívia ^a   Juhász, Anna ^a   Laskay, Gábor ^a   Hetényi, Csaba ^a,b   Mihalik, Erzsébet ^a   Zarándi, Márta ^a   Penke, Botond ^a,c  

^a UNIVERSITY OF SZEGED   (Hungary)

^b EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Amyloid; Aggregation; Neurite degeneration; Neuroblastoma cells; Neuroprotection

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; LEUCYLPROLYLTYROSYLPHENYLALANYLASPARTIC ACID; NEUROPROTECTIVE AGENT; PENTAPEPTIDE; TAU PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CONTACT; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IN VITRO STUDY; MORPHOLOGY; NERVE CELL DEGENERATION; NERVE DEGENERATION; NEUROBLASTOMA CELL; NEUROPATHY; NEUROTOXICITY; OXIDATION REDUCTION REACTION; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN AGGREGATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; CELL LINE, TUMOR; HUMANS; MICROSCOPY, ELECTRON, SCANNING; NERVE TISSUE PROTEINS; NEUROFIBRILS; NEUROTOXINS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; TIME FACTORS;

EID: 9644291529     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2004.08.007     Document Type: Article

References (33)

1. R. Brandt Cytoskeletal mechanisms of neuronal degeneration Cell Tissue Res. 305 2001 255 265 (Review)
2. D.B. Carter, and K.C. Chou A model for structure-dependent binding of Congo red to Alzheimer beta-amyloid fibrils Neurobiol. Aging 19 1998 37 40
3. Z. Datki, A. Juhász, M. Gálfi, K. Soós, R. Papp, D. Zádori, and B. Penke Method for measuring neurotoxicity of aggregating polypeptides with the MTT assay on differentiated neuroblastoma cells Brain Res. Bull. 62 2003 223 229
4. E.A. Grace, and J. Busciglio Aberrant activation of focal adhesion proteins mediates fibrillar amyloid beta-induced neuronal dystrophy J. Neurosci. 23 2003 493 502
5. E.A. Grace, C.A. Rabiner, and J. Busciglio Characterization of neuronal dystrophy induced by fibrillar amyloid beta: implications for Alzheimer's disease Neuroscience 114 2002 265 273
6. M. Hamdane, P. Delobel, A.V. Sambo, C. Smet, S. Begard, A. Violleau, I. Landrieu, A. Delacourte, G. Lippens, S. Flament, and L. Buee Neurofibrillary degeneration of the Alzheimer-type: an alternate pathway to neuronal apoptosis? Biochem. Pharmacol. 66 2003 1619 1625 (Review)
7. C. Hetenyi, Z. Szabo, E. Klement, Z. Datki, T. Kortvelyesi, M. Zarandi, and B. Penke Pentapeptide amides interfere with the aggregation of beta-amyloid peptide of Alzheimer's disease Biochem. Biophys. Res. Commun. 292 2002 931 936
8. C. Hetenyi, T. Kortvelyesi, and B. Penke Mapping of possible binding sequences of two beta-sheet breaker peptides on beta amyloid peptide of Alzheimer's disease Bioorg. Med. Chem. 10 2002 1587 1593
9. M. Higuchi, V.M. Lee, and J.Q. Trojanowski Tau and axonopathy in neurodegenerative disorders Neuromol. Med. 2 2002 131 150
10. K. Ishiguro, H. Ohno, H. Arai, H. Yamaguchi, K. Urakami, J.M. Park, K. Sato, H. Kohno, and K. Imahori Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease Neurosci. Lett. 270 1999 91 94
11. R. Khurana, V.N. Uversky, L. Nielsen, and A.L. Fink Is Congo red an amyloid-specific dye? J. Biol. Chem. 276 2001 22715 22721
12. W.E. Klunk, R.F. Jacob, and R.P. Mason Quantifying amyloid beta-peptide (Abeta) aggregation using the Congo red-Abeta (CR-abeta) spectrophotometric assay Anal. Biochem. 266 1999 66 76
13. M.P. Lambert, G. Stevens, S. Sabo, K. Barber, G. Wang, W. Wade, G. Krafft, S. Snyder, T.F. Holzman, and W.L. Klein Beta/A4-evoked degeneration of differentiated SH-SY5Y human neuroblastoma cells J. Neurosci. Res. 39 1994 377 385
14. Y.P. Li, A.F. Bushnell, C.M. Lee, L.S. Perlmutter, and S.K. Wong Beta-amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells Brain Res. 738 1996 196 204
15. Y. Liu, and D. Schubert Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis J. Neurochem. 69 1997 2285 2293
16. Y. Liu, D.A. Peterson, H. Kimura, and D. Schubert Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction J. Neurochem. 69 1997 581 593
17. D.T. Loo, A. Copani, C.J. Pike, E.R. Whittemore, A.J. Walencewicz, and C.W. Cotman Apoptosis is induced by beta-amyloid in cultured central nervous system neurons Proc. Natl. Acad. Sci. U. S. A. 90 1993 7951 7955
18. C. Loske, A. Neumann, A.M. Cunningham, K. Nichol, R. Schinzel, P. Riederer, and G. Munch Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress J. Neural Transm. 105 1998 1005 1015
19. P. Mookherjee, and G.V. Johnson Tau phosphorylation during apoptosis of human SH-SY5Y neuroblastoma cells Brain Res. 921 2001 31 43
20. Y. Morishima, Y. Gotoh, J. Zieg, T. Barrett, H. Takano, R. Flavell, R.J. Davis, Y. Shirasaki, and M.E. Greenberg Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand J. Neurosci. 21 2001 7551 7560
21. M. Nordin-Andersson, A. Forsby, N. Heldring, J. DeJongh, P. Kjellstrand, and E. Walum Neurite degeneration in differentiated human neuroblastoma cells Toxicol. In Vitro 12 1998 557 560
22. M. Rapoport, H.N. Dawson, L.I. Binder, M.P. Vitek, and A. Ferreira Tau is essential to beta-amyloid-induced neurotoxicity Proc. Natl. Acad. Sci. U. S. A. 99 2002 6364 6369
23. D.J. Selkoe Alzheimer's disease is a synaptic failure Science 298 2002 789 791
24. E.M. Sigurdsson, B. Permanne, C. Soto, T. Wisniewski, and B. Frangione In vivo reversal of amyloid-beta lesions in rat brain J. Neuropathol. Exp. Neurol. 59 2000 11 17
25. C. Soto, E.M. Sigurdsson, L. Morelli, R.A. Kumar, E.M. Castano, and B. Frangione Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy Nat. Med. 4 1998 822 826
26. C. Soto, G.P. Saborio, and B. Permanne Inhibiting the conversion of soluble amyloid-beta peptide into abnormally folded amyloidogenic intermediates: relevance for Alzheimer's disease therapy Acta. Neurol. Scand., Suppl. 176 2000 90 95
27. D. Terwel, L. Dewachter, and F. Van Leuven Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease Neuromol. Med. 2 2002 151 165
28. L.O. Tjernberg, J. Naslund, F. Lindqvist, J. Johansson, A.R. Karlstrom, J. Thyberg, L. Terenius, and C. Nordstedt Arrest of beta-amyloid fibril formation by a pentapeptide ligand J. Biol. Chem. 271 1996 8545 8548
29. Y. Tomidokoro, K. Ishiguro, Y. Harigaya, E. Matsubara, M. Ikeda, J.M. Park, K. Yasutake, T. Kawarabayashi, K. Okamoto, and M. Shoji Abeta amyloidosis induces the initial stage of tau accumulation in APP (Sw) mice Neurosci. Lett. 299 2001 169 172
30. F. Torreilles, and J. Touchon Pathogenic theories and intrathecal analysis of the sporadic form of Alzheimer's disease Prog. Neurobiol. 66 2002 191 203 (Review)
31. J.C. Vickers, T.C. Dickson, P.A. Adlard, H.L. Saunders, C.E. King, and G. McCormack The cause of neuronal degeneration in Alzheimer's disease Prog. Neurobiol. 60 2000 139 165
32. D.M. Walsh, A. Lomakin, G.B. Benedek, M.M. Condron, and D.B. Teplow Amyloid β-protein fibrillogenesis J. Biol. Chem. 272 1997 22364 22372
33. H. Wei, P.R. Leeds, Y. Qian, W. Wei, R. Chen, and D. Chuang Beta-amyloid peptide-induced death of PC 12 cells and cerebellar granule cell neurons is inhibited by long-term lithium treatment Eur. J. Pharmacol. 392 2000 117 123